Advertisement

Topics

MorphoSys reports positive data from DLBCL candidate's midstage trial

05:47 EDT 17 May 2019 | SmartBrief

MorphoSys announced the completion of its midstage trial that assessed its lead candidate, MOR208, in combination with Celgen -More

Original Article: MorphoSys reports positive data from DLBCL candidate's midstage trial

NEXT ARTICLE

More From BioPortfolio on "MorphoSys reports positive data from DLBCL candidate's midstage trial"

Advertisement
Quick Search
Advertisement
Advertisement